Alliance Pharma Share Price | |
---|---|
Price | 34.95 |
Bid | 34.85 |
Ask | 35.00 |
Change | 0.05 (0.14%) |
Volume | 330,994 |
Open | 35.75 |
High | 35.75 |
Low | 34.45 |
Prev. Close | 34.90 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 540.40m |
Market Capitalisation | £188.87m |
Market Size | 20,000 |
52 Week High | 72.60 |
52 Week High Date | 17-May-2023 |
52 Week Low | 33.70 |
52 Week Low Date | 10-Nov-2023 |
# Trades | 108 |
---|---|
Vol. Sold | 173,694 |
Sold Value | £60.52k |
Vol. Bought | 123,597 |
Bought Value | £43.07k |
PE Ratio | 205.58824 |
Earnings | 0.17 |
Dividend | 1.691 |
Yield | 4.838% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
26-Apr-24 | 17:46:25 | 34.95 | 3,993 | Unknown* | 34.85 | 35.00 | 1,396 | O Ordinary Was reported as OTC |
26-Apr-24 | 17:42:55 | 34.948 | 3,184 | Unknown* | 34.85 | 35.00 | 1,113 | O Ordinary Was reported as OTC |
26-Apr-24 | 17:42:55 | 34.949 | 469 | Unknown* | 34.85 | 35.00 | 163.91 | O Ordinary Was reported as OTC |
26-Apr-24 | 17:33:43 | 34.893 | 21,396 | Unknown* | 34.85 | 35.00 | 7,466 | O Ordinary Was reported as OTC |
26-Apr-24 | 17:21:05 | 34.95 | 3,181 | Unknown* | 34.85 | 35.00 | 1,112 | O Ordinary Was reported as OTC |
26-Apr-24 | 16:35:09 | 34.95 | 16,597 | Sell* | 34.85 | 35.00 | 5,801 | UT Uncrossing Trade |
26-Apr-24 | 16:29:46 | 35.00 | 6 | Buy* | 34.85 | 35.00 | 2.10 | A Automatic Execution |
26-Apr-24 | 16:29:46 | 35.00 | 6 | Buy* | 34.85 | 35.00 | 2.10 | A Automatic Execution |
26-Apr-24 | 16:29:46 | 35.00 | 7 | Buy* | 34.85 | 35.00 | 2.45 | A Automatic Execution |
26-Apr-24 | 16:29:46 | 35.00 | 19 | Buy* | 34.85 | 35.00 | 6.65 | A Automatic Execution |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
16-Oct-23 | 13-Oct-23 | Exercise of Option | Andrew Franklin held the position of CFO at the time of this trade.Andrew Franklin | 1.00 | GBX | 55,592 | 248,503 |
16-Oct-23 | 13-Oct-23 | Sell | Peter Butterfield held the position of CEO at the time of this trade.Peter Butterfield | 39.02 | GBX | 74,343 | 696,686 |
16-Oct-23 | 13-Oct-23 | Sell | Andrew Franklin held the position of CFO at the time of this trade.Andrew Franklin | 39.02 | GBX | 42,053 | 248,503 |
16-Oct-23 | 13-Oct-23 | Exercise of Option | Peter Butterfield held the position of CEO at the time of this trade.Peter Butterfield | 1.00 | GBX | 98,342 | 696,686 |
20-Jul-23 | 20-Jul-23 | Buy | Jo Le Couilliard held the position of Chairman at the time of this trade.Jo Le Couilliard | 48.80 | GBX | 40,957 | 40,957 |
We have a proven, consistent track record that enables us to invest for both organic growth and acquisitions